- Cannabis and Cannabinoid Research
- Psychedelics and Drug Studies
- Forensic Toxicology and Drug Analysis
- Substance Abuse Treatment and Outcomes
- Tryptophan and brain disorders
- Bipolar Disorder and Treatment
- Homelessness and Social Issues
- Sleep and related disorders
- Chemical synthesis and alkaloids
- Complementary and Alternative Medicine Studies
- Treatment of Major Depression
- Suicide and Self-Harm Studies
- Mental Health Treatment and Access
- Religion, Spirituality, and Psychology
- Sexuality, Behavior, and Technology
- Prenatal Substance Exposure Effects
- Sleep and Wakefulness Research
- Attention Deficit Hyperactivity Disorder
- Sports Analytics and Performance
- Antibiotic Resistance in Bacteria
- Intergenerational Family Dynamics and Caregiving
- Doping in Sports
- Alcoholism and Thiamine Deficiency
- Gambling Behavior and Treatments
- Bee Products Chemical Analysis
University of California, San Diego
2020-2025
University of Michigan
2024
Barrett Hospital & HealthCare
2023
Rady Children's Hospital-San Diego
2022
Abstract Anorexia nervosa (AN) is a deadly illness with no proven treatments to reverse core symptoms and medications approved by the US Food Drug Administration. Novel are urgently needed improve clinical outcomes. In this open-label feasibility study, 10 adult female participants (mean body mass index 19.7 kg m − 2 ; s.d. 3.7) who met Diagnostic Statistical Manual of Mental Disorders , Fifth Edition (DSM-5) criteria for AN or pAN (partial remission) were recruited study conducted at an...
BACKGROUND/OBJECTIVES Use of cannabis is increasing in a variety populations the United States; however, few investigations about how and for what reasons used older exist. DESIGN Anonymous survey. SETTING Geriatrics clinic. PARTICIPANTS A total 568 adults 65 years older. INTERVENTION Not applicable. MEASUREMENTS Survey assessing characteristics use. RESULTS Approximately 15% (N = 83) survey responders reported using within past 3 years. Half (53%) regularly on daily or weekly basis,...
Psychedelic serotonergic agonists such as psilocybin have recently been shown to produce sustained benefit in refractory depression, end of life anxiety, and addiction when administered hallucinogenic doses coupled with psychotherapy. Although it has suggested that similar high-dose protocols may help chronic pain conditions, there are few published clinical trials psychedelics for pain. The use these agents subpsychedelic management received even less attention. This case series details the...
Importance Despite growing interest in psychedelics, there is a lack of routine population-based surveillance psychedelic microdosing (taking “subperceptual” doses approximately one-twentieth to one-fifth full dose, over prolonged periods). Analyzing Google search queries can provide insights into public and help address this gap. Objective To analyze trends the US through assess their association with cannabis legislative reforms. Design, Setting, Participants In cross-sectional study,...
Little is known about ecstasy/MDMA use among Asian American and Pacific Islander populations. Research important because AAPIs face unique cultural factors that may influence use. We estimated the prevalence correlates of lifetime based on a representative sample US AAPI adults aged ≥18 from 2015–2020 National Survey Drug Use Health. An 5.1% used ecstasy in their lifetime. Compared to males, females had higher odds (aOR = 1.45, 95% CI: 1.08–1.98). those 18–25, 26–34 were at increased for...
3,4-Methylenedioxymethamphetamine (MDMA) (also known as "ecstasy" or "Molly") has regained attention in recent years for its efficacy treating posttraumatic stress disorder, and the drug was granted breakthrough therapy designation such use by US Food Drug Administration 2017. However, little is about current epidemiology of recreational ecstasy/MDMA use.
Abstract Background and Objectives Ketamine is efficacious in treating treatment‐resistant depression medical settings the drug was approved for such use by US Federal Drug Administration 2019. However, little known about how outside of relates to depression. We determined whether recreational ketamine use, relative other drugs, related current experience among adolescents. Methods examined data from 2016 2019 Monitoring Future nationally representative survey high school seniors United...
Cannabis use is growing among older adults to manage medical concerns including poor sleep. In this study, we characterized how patients seen at a geriatrics clinic cannabis address sleep disturbance. Specifically, conducted an anonymous survey of 568 adults, 83 who reported within the past 3 years, inquire about such use. We compared characteristics between those using it for disturbance versus all other conditions. considered
Anorexia nervosa (AN) is a deadly illness with no proven treatments to reverse core symptoms and medications approved by the US Food Drug Administration. Novel are urgently needed improve clinical outcomes. In this open-label feasibility study, 10 adult female participants (mean body mass index 19.7 kg m
Neuroendocrine cell hyperplasia of infancy (NEHI) is a rare childhood interstitial lung disease characterized by gradual onset tachypnea, hypoxemia, and failure to thrive in the first 2 years life. NEHI challenging diagnose can masquerade as common respiratory infections reactive airway disease. Timely diagnosis essential optimize management comorbidities, improve outcomes, prevent unnecessary interventions. We report case 14-month-old male who was hospitalized multiple times with recurrent...
While there is increasing interest in the use of cannabis to manage a range health-related symptoms, little known about trends recent with respect various health conditions and whether may be disproportionate increases among individuals certain conditions. We examined data from US representative sample noninstitutionalized adults age ≥18 2015-2019 National Survey on Drug Use Health (N=214,505). estimated linear time prevalence past-month stratified by disability (i.e., difficulty hearing,...
Abstract Cannabis may be useful for treatment of sleep problems in older adults. Little is known about use patterns cannabis sleep. We conducted a clinic-based anonymous survey geriatrics clinic La Jolla, CA. Among n=568 surveys, 10% reported recent (within past 6 months). users, 30% using sleep, most finding it helpful. Compared to users other conditions, were more likely THC containing products (62.5% vs. 32.1%), on daily or weekly basis (76.2% 43.2%), vape pens (29.2% 6.9%), and obtain...